PMC:7546122 / 13211-13618 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T68","span":{"begin":218,"end":225},"obj":"Body_part"},{"id":"T69","span":{"begin":400,"end":406},"obj":"Body_part"}],"attributes":[{"id":"A68","pred":"fma_id","subj":"T68","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A69","pred":"fma_id","subj":"T69","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"The current study, as well as an earlier study that tested 21 IVIG lots (9 Gamunex C, 10 Gammagard Liquid, 2 other) with a SARS-CoV-2-specific enzyme-linked immunosorbent assay (ELISA; receptor-binding domain or spike protein) that was shown to correlate well with a neutralization test [14] revealed the absence of cross-reactive antibodies against SARS-CoV-2 in IVIG lots produced from prepandemic plasma."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T66","span":{"begin":123,"end":131},"obj":"Disease"},{"id":"T67","span":{"begin":350,"end":358},"obj":"Disease"}],"attributes":[{"id":"A66","pred":"mondo_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A67","pred":"mondo_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"The current study, as well as an earlier study that tested 21 IVIG lots (9 Gamunex C, 10 Gammagard Liquid, 2 other) with a SARS-CoV-2-specific enzyme-linked immunosorbent assay (ELISA; receptor-binding domain or spike protein) that was shown to correlate well with a neutralization test [14] revealed the absence of cross-reactive antibodies against SARS-CoV-2 in IVIG lots produced from prepandemic plasma."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T134","span":{"begin":52,"end":58},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T135","span":{"begin":121,"end":122},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T136","span":{"begin":265,"end":266},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T137","span":{"begin":282,"end":286},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T138","span":{"begin":400,"end":406},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"The current study, as well as an earlier study that tested 21 IVIG lots (9 Gamunex C, 10 Gammagard Liquid, 2 other) with a SARS-CoV-2-specific enzyme-linked immunosorbent assay (ELISA; receptor-binding domain or spike protein) that was shown to correlate well with a neutralization test [14] revealed the absence of cross-reactive antibodies against SARS-CoV-2 in IVIG lots produced from prepandemic plasma."}

{"project":"LitCovid-sentences","denotations":[{"id":"T96","span":{"begin":0,"end":407},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The current study, as well as an earlier study that tested 21 IVIG lots (9 Gamunex C, 10 Gammagard Liquid, 2 other) with a SARS-CoV-2-specific enzyme-linked immunosorbent assay (ELISA; receptor-binding domain or spike protein) that was shown to correlate well with a neutralization test [14] revealed the absence of cross-reactive antibodies against SARS-CoV-2 in IVIG lots produced from prepandemic plasma."}

{"project":"LitCovid-PubTator","denotations":[{"id":"252","span":{"begin":212,"end":217},"obj":"Gene"},{"id":"253","span":{"begin":123,"end":133},"obj":"Species"},{"id":"254","span":{"begin":350,"end":360},"obj":"Species"}],"attributes":[{"id":"A252","pred":"tao:has_database_id","subj":"252","obj":"Gene:43740568"},{"id":"A253","pred":"tao:has_database_id","subj":"253","obj":"Tax:2697049"},{"id":"A254","pred":"tao:has_database_id","subj":"254","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The current study, as well as an earlier study that tested 21 IVIG lots (9 Gamunex C, 10 Gammagard Liquid, 2 other) with a SARS-CoV-2-specific enzyme-linked immunosorbent assay (ELISA; receptor-binding domain or spike protein) that was shown to correlate well with a neutralization test [14] revealed the absence of cross-reactive antibodies against SARS-CoV-2 in IVIG lots produced from prepandemic plasma."}

{"project":"2_test","denotations":[{"id":"32941626-32398876-61082437","span":{"begin":288,"end":290},"obj":"32398876"}],"text":"The current study, as well as an earlier study that tested 21 IVIG lots (9 Gamunex C, 10 Gammagard Liquid, 2 other) with a SARS-CoV-2-specific enzyme-linked immunosorbent assay (ELISA; receptor-binding domain or spike protein) that was shown to correlate well with a neutralization test [14] revealed the absence of cross-reactive antibodies against SARS-CoV-2 in IVIG lots produced from prepandemic plasma."}